Oncolytic adenoviruses: a game changer approach in the battle between cancer and the immune system.

Tutkimustuotos: ArtikkelijulkaisuKatsausartikkeliTieteellinenvertaisarvioitu

Alkuperäiskielienglanti
LehtiExpert Opinion on Biological Therapy
Vuosikerta19
Numero5
Sivut443-455
Sivumäärä13
ISSN1471-2598
DOI - pysyväislinkit
TilaJulkaistu - 4 toukokuuta 2019
OKM-julkaisutyyppiA2 Katsausartikkeli tieteellisessä aikakauslehdessä

Tieteenalat

  • 318 Lääketieteen bioteknologia
  • 1183 Kasvibiologia, mikrobiologia, virologia

Lainaa tätä

@article{65dcfd30555a403d9fb59cc6d0b9ef7a,
title = "Oncolytic adenoviruses: a game changer approach in the battle between cancer and the immune system.",
keywords = "Immunovirotherapy, oncolytic adenovirus, viral vectors, adoptive-cell transfer, CAR T cell therapy, TCR gene therapy, checkpoint inhibitors, immunotherapy, CHIMERIC ANTIGEN RECEPTOR, ENGINEERED T-CELLS, COLONY-STIMULATING FACTOR, NECROSIS-FACTOR-ALPHA, PHASE-I, METASTATIC MELANOMA, GM-CSF, RECOMBINANT INTERLEUKIN-2, CHECKPOINT INHIBITORS, DOSE CYCLOPHOSPHAMIDE, 318 Medical biotechnology, 1183 Plant biology, microbiology, virology",
author = "Victor Cervera-Carrascon and Riikka Havunen and Akseli Hemminki",
year = "2019",
month = "5",
day = "4",
doi = "10.1080/14712598.2019.1595582",
language = "English",
volume = "19",
pages = "443--455",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Taylor & Francis",
number = "5",

}

Oncolytic adenoviruses : a game changer approach in the battle between cancer and the immune system. / Cervera-Carrascon, Victor; Havunen, Riikka; Hemminki, Akseli.

julkaisussa: Expert Opinion on Biological Therapy, Vuosikerta 19, Nro 5, 04.05.2019, s. 443-455.

Tutkimustuotos: ArtikkelijulkaisuKatsausartikkeliTieteellinenvertaisarvioitu

TY - JOUR

T1 - Oncolytic adenoviruses

T2 - a game changer approach in the battle between cancer and the immune system.

AU - Cervera-Carrascon, Victor

AU - Havunen, Riikka

AU - Hemminki, Akseli

PY - 2019/5/4

Y1 - 2019/5/4

KW - Immunovirotherapy

KW - oncolytic adenovirus

KW - viral vectors

KW - adoptive-cell transfer

KW - CAR T cell therapy

KW - TCR gene therapy

KW - checkpoint inhibitors

KW - immunotherapy

KW - CHIMERIC ANTIGEN RECEPTOR

KW - ENGINEERED T-CELLS

KW - COLONY-STIMULATING FACTOR

KW - NECROSIS-FACTOR-ALPHA

KW - PHASE-I

KW - METASTATIC MELANOMA

KW - GM-CSF

KW - RECOMBINANT INTERLEUKIN-2

KW - CHECKPOINT INHIBITORS

KW - DOSE CYCLOPHOSPHAMIDE

KW - 318 Medical biotechnology

KW - 1183 Plant biology, microbiology, virology

U2 - 10.1080/14712598.2019.1595582

DO - 10.1080/14712598.2019.1595582

M3 - Review Article

VL - 19

SP - 443

EP - 455

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 5

ER -